Kestra Medical Technologies
Kirkland, Washington, United States · Biotechnology, Health Care, Medical
Kestra Medical Technologies, Inc. is a privately held wearable medical device and digital healthcare company that protects cardiac patients with diagnostic monitoring and therapeutic technologies. Kestra was founded in 2014 by Bain Capital private equity and leaders from the external (AED) and internal (ICD) defibrillation industries.
Key facts
- Headquarters
- Kirkland, Washington, United States
- Employees
- 275
- Industries
- Biotechnology, Health Care, Medical
- Status
- Public (KMTS)
- Website
- kestramedical.com
- Company page
Recent activity at Kestra Medical Technologies
- : SEC 8-K (5.02): On September 9, 2026, Kestra Medical Technologies, Ltd. held its 2026 annual general meeting of shareholders, during which shareholders voted on the election of directors. A total of 55,399,491 common shares were voted, representing approximately 94.53% of the outstanding shares entitled to vote as of the record date, July 17, 2026. The shareholders elected three nominees to serve as Class II directors until the 2029 annual meeting. This event reflects the ongoing governance and management continuity for the company, significant given its potential strategic implications for future operations and leadership stability.
- : Kestra Medical Technologies Appoints Curtis Kopf as Senior Vice President of Customer Experience
- : Kestra Technologies raises $25 million in Series A funding led by RTP Global to enhance its orchestration platform and expand its operations.
- : Kestra Medical Technologies partners with Biobeat to enhance blood pressure monitoring for cardiac recovery.
- : Kestra Medical Technologies Raises $158.7 Million in Public Offering
- : SEC 8-K (1.01): On December 2, 2025, Kestra Medical Technologies, Ltd. entered into an Underwriting Agreement with BofA Securities, Inc., Piper Sandler & Co., J.P. Morgan Securities LLC, and Goldman Sachs & Co. LLC for a public offering of 6,900,000 common shares at a purchase price of $23.00 per share. The Offering included an additional 900,000 shares from the Underwriters' option to purchase more at the same price, which is typical in such financial agreements. This capital raising activity indicates a strategy to strengthen the company's financial position and expand its market presence, with the total proceeds expected to significantly support future investments and operational initiatives.
- : Kestra Medical Technologies Appoints Timothy Moran as Chief Business Officer
- : Kestra Medical Technologies raised $196 million in an oversubscribed financing round co-led by Andera Partners, Ally Bridge Group, Longitude Capital and Omega Funds.
Kestra Medical Technologies funding history
| Date | Round | Amount |
|---|---|---|
| Apr 2026 | Series A | $25.0M |
| Dec 2025 | Post-IPO Equity | $158.7M |
| Jul 2024 | Funding Round | $196.0M |
Leadership
- Jaylene Belcher, Director, Talent Acquisition and People Development
- Ashley Bailey, Director of Training and Education
- Matt Eckert, Regional Sales Director
- Jennifer Imerini, Director of Field Service Operations
- Ashley Bailey, Director of Training & Education
- Curtis Kopf, Senior Vice President
- Brian Webster, Chief Executive Officer
- Timothy Moran, Chief Business Officer
- Keith Claeys, Vice President of Finance
- Brian Webster, Chief Executive Officer
Verified email and direct lines for Kestra Medical Technologies’s decision-makers are on Fundz. See plans — or book a 15-minute walkthrough.
Employee benefit plans
Kestra Medical Technologies files 2 employee benefit plans with the U.S. Department of Labor, including a retirement plan. The next plan year renews in Dec 2026.
Kestra Medical Technologies in the news
- Kestra Medical Technologies Reports Third Quarter Fiscal 2026 Financial Results - GlobeNewswire (Mar 17, 2026)
- Kestra Medical Technologies celebrates 1-year anniversary of Southlake office - Community Impact Newspaper (Aug 03, 2026)
- Kestra Medical Technologies Announces Strategic Collaboration with Biobeat Technologies to Expand Diagnostic Insight for Wearable Defibrillator Patients During Cardiac Recovery - BioSpace (Jan 13, 2026)
- Kestra Medical Technologies Appoints Daniel Finney as Vice President of Research & Development - Quiver Quantitative (Sep 10, 2026)
- Kestra Medical Technologies Reports Fourth Quarter and Fiscal Year 2026 Financial Results - GlobeNewswire (Jul 14, 2026)
- Kestra Medical Technologies Secures Up to $200 Million of Non-Dilutive Financing - GlobeNewswire (Jul 14, 2026)
- Kestra Medical Technologies Offers Electrophysiology and Cardiology Clinicians Opportunity to Wear ASSURE WCD System at #HRX2023 Conference - BioSpace (Sep 22, 2023)
- Kestra Medical Technologies Reports First Quarter Fiscal 2027 Financial Results - GlobeNewswire (Sep 14, 2026)
Companies similar to Kestra Medical Technologies
- GC Aesthetics · Biotechnology, Health Care, Medical, Medical Device
- Biocomposites · Biotechnology, Health Care, Medical, Medical Device
- Minnetronix Medical · Biotechnology, Health Care, Medical, Medical Device
- Bethesda Medical · Biotechnology, Health Care, Medical, Medical Device
- NorthStar Medical Technologies · Biotechnology, Health Care, Medical, Medical Device
About Kestra Medical Technologies: questions and answers
What does Kestra Medical Technologies do?
Kestra Medical Technologies, Inc. is a privately held wearable medical device and digital healthcare company that protects cardiac patients with diagnostic monitoring and therapeutic technologies. Kestra was founded in 2014 by Bain Capital private equity and leaders from the external (AED) and internal (ICD) defibrillation industries.
Where is Kestra Medical Technologies headquartered?
Kestra Medical Technologies is headquartered in Kirkland, Washington, United States.
How many employees does Kestra Medical Technologies have?
Kestra Medical Technologies has about 275 employees.
Has Kestra Medical Technologies raised funding?
Yes. Fundz has recorded 3 funding events for Kestra Medical Technologies. The most recent, Series A of $25.0M, was in Apr 2026.
Who leads Kestra Medical Technologies?
Curtis Kopf is a Senior Vice President at Kestra Medical Technologies.
What is the latest news on Kestra Medical Technologies?
On Sep 09, 2026, SEC 8-K (5.02): On September 9, 2026, Kestra Medical Technologies, Ltd. held its 2026 annual general meeting of shareholders, during which shareholders voted on the election of directors. A total of 55,399,491 common shares were voted, representing approximately 94.53% of the outstanding shares enti
Is Kestra Medical Technologies a public company?
Yes. Kestra Medical Technologies is publicly traded under the ticker KMTS.
Source: Fundz records from SEC filings, press releases and company announcements. How Fundz measures data accuracy